Related Experiment Video
Updated: Feb 12, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
[Current trends in diagnosis and treatment of giant cell arteritis]
Michael Czihal1, Christian Lottspeich1, Ulrich Hoffmann1
1Med. Klinik und Poliklinik IV, Sektion Angiologie-Gefäßzentrum, Klinikum der Ludwig-Maximilians-Universität, München.
Insights
Giant cell arteritis (GCA) is a common vasculitis in older adults. This review covers new diagnostic tools like ultrasound and treatments such as tocilizumab for managing GCA.
Area of Science:
- Rheumatology
- Internal Medicine
- Vasculitis Research
Background:
- Giant cell arteritis (GCA) is the most prevalent primary large vessel vasculitis.
- GCA predominantly affects individuals aged 50 years and older.
- Effective management is crucial for preventing complications.
Purpose of the Study:
- To review current management strategies for Giant cell arteritis (GCA).
- To highlight recent advancements in diagnostic sonographic assessments.
- To discuss emerging biological treatments for GCA.
Main Methods:
- Review of current literature on GCA management.
- Discussion of sonographic techniques including B-mode sonography and contrast-enhanced ultrasound.
- Analysis of biological treatments, specifically tocilizumab.
Main Results:
- Sonographic assessments offer improved diagnostic capabilities for GCA.
- Tocilizumab, an IL-6 receptor inhibitor, represents a significant advancement in GCA treatment.
- Current trends focus on integrating advanced imaging and targeted biological therapies.
Conclusions:
- Sonography plays an increasingly important role in GCA diagnosis and monitoring.
- Tocilizumab provides a novel therapeutic option for GCA management.
- Integrated approaches combining advanced diagnostics and targeted therapies are shaping the future of GCA care.
Abstract:
Giant cell arteritis (GCA) is the most common form of the primary large vessel vasculitides and typically occurs in individuals aged ≥ 50 years. This concise review article discusses current trends in the management of GCA, including important developments in sonographic assessment (B-mode sonography, contrast enhanced ultrasound) and medical treatment (biological treatment with the interleukin-6 receptor alpha inhibitor tocilizumab).
Related Concept Videos
Current Trends in Nursing I
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Electrical Current
Trends in Lattice Energy: Ion Size and Charge

